Mark L. Welton
- Oncology top 1%
- Colorectal Cancer Surgical Treatments 12
- Colorectal Cancer Screening and Detection 5
- Viral-associated cancers and disorders 5
- Surgery top 1%
- Colorectal and Anal Carcinomas 26
- Anorectal Disease Treatments and Outcomes 5
- Gastroenterology top 2%
-
- Genetic factors in colorectal cancer 4
- Epidemiology top 2%
- Cervical Cancer and HPV Research 20
-
- Neuropeptides and Animal Physiology 6
- Co-authors
- Joel M. PalefskyJ. Michael BerryAndrew SheltonDaniel J. SargentCarolyn C. ComptonStanley R. HamiltonDonald E. HensonL P Fielding
- Cited by
- OncologySurgeryGastroenterology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (1 paper)Gastroenterology (1 paper)
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
Mark L. Welton
66 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 1.9k
- Surgery 2.1k
- Gastroenterology 240
- Pathology and Forensic Medicine 584
- Epidemiology 988
Countries citing papers authored by Mark L. Welton
This map shows the geographic impact of Mark L. Welton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Welton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Welton more than expected).
Fields of papers citing papers by Mark L. Welton
This network shows the impact of papers produced by Mark L. Welton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Welton. The network helps show where Mark L. Welton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark L. Welton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2020 | 8 | |
| 3 | 2017 | 3 | |
| 4 | 2016 | 23 | |
| 5 | 2015 | 103 | |
| 6 | 2013 | 50 | |
| 7 | 2013 | 18 | |
| 8 | 2012 | 248 | |
| 9 | 2009 | 20 | |
| 10 | 2007 | 29 | |
| 11 | 2007 | 43 | |
| 12 | 2005 | 68 | |
| 13 | 2005 | 14 | |
| 14 | 2000 | 19 | |
| 15 | 2000 | 24 | |
| 16 | General practitioners' use of aspirin in the secondary prevention of vascular events: knowledge, attitudes, and current practice. | 1999 | 9 |
| 17 | 1991 | 67 | |
| 18 | 1989 | 30 | |
| 19 | 1989 | 112 | |
| 20 | 1988 | 1 |
About Mark L. Welton
Mark L. Welton is a scholar working on Surgery, Oncology and Gastroenterology, having authored 66 papers that have together received 3.7k indexed citations. Recurring topics across this work include Colorectal and Anal Carcinomas (26 papers), Cervical Cancer and HPV Research (20 papers), Colorectal Cancer Surgical Treatments (12 papers), Neuropeptides and Animal Physiology (6 papers), Anorectal Disease Treatments and Outcomes (5 papers), Colorectal Cancer Screening and Detection (5 papers), Viral-associated cancers and disorders (5 papers) and Genetic factors in colorectal cancer (4 papers). The work is most often cited by research in Oncology (1.9k citations), Surgery (2.1k citations) and Gastroenterology (240 citations). Mark L. Welton has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Joel M. Palefsky, J. Michael Berry, Andrew Shelton, Daniel J. Sargent, Carolyn C. Compton, Stanley R. Hamilton, Donald E. Henson, L P Fielding, Christopher G. Willett and R. V. P. Hutter. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.